UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Obese people more vulnerable to Covid-19’
A researcher at Seoul National University Bundang Hospital and the compilin...
by Lee Han-soo
|
2020-07-16 17:30
라인
SNUH develops new nanoparticle to improve hyperthermia treatment for cancer
A research team at the Seoul National University Hospital (SNUH) has develo...
by Lee Han-soo
|
2020-07-16 16:39
라인
Leukemia patients suffer from shortage of platelet donors
Leukemia patients are finding it increasingly difficult to get timely plate...
by Song Soo-youn
|
2020-07-16 15:58
라인
Hanmi’s fatty liver drug won FDA’s fast-track designation
Hanmi Pharmaceutical said Thursday that the U.S. Food and Drug Administrati...
by Shim Hyun-tai
|
2020-07-16 15:57
라인
Genbody to export 2nd Covid-19 diagnostic kit
Genbody said Thursday that it will launch "GenBody COVID-19 Ag," a rapid an...
by Lee Han-soo
|
2020-07-16 14:39
라인
‘Stage-3 unresectable lung cancer patient has every reason to use Imfinzi’
“Before Imfinzi arrived, all physicians could do for a state-3 unresectable...
by Kim Yun-mi
|
2020-07-16 14:37
라인
Menarini Korea deletes controversial YouTube ad
Menarini Korea’s online advertisement of an athlete’s foot treatment depict...
by Kim Chan-hyuk
|
2020-07-16 14:16
라인
Unrelenting imported cases push up Covid-19 outbreaks
Korea's new virus cases rose above 60 on Thursday, as imported infectio...
by Lee Han-soo
|
2020-07-16 11:44
라인
Samsung Biologics to develop 5 more cancer therapies of ImmuneOncia
Samsung Biologics said Wednesday that it has signed a CDO (contract develop...
by Shim Hyun-tai
|
2020-07-15 18:33
라인
Regulators approved 13 new medical products in Q2
The Ministry of Food and Drug Safety said Wednesday that it approved 13 new...
by Shim Hyun-tai
|
2020-07-15 17:34
라인
Ajou to build cancer precision medicine platform with Syapse
Ajou University Medical Center (AUMC) Tuesday held a kickoff event with Sya...
by Shim Hyun-tai
|
2020-07-15 16:28
라인
Health experts support government’s telemedicine drive
Healthcare experts expressed positive views on the government’s push for th...
by Choi Gwang-seok
|
2020-07-15 16:27
라인
Korea, Italy to discuss cooperation for Covid-19 research
The Korea National Institute of Health, a research body under the Korea Cen...
by Choi Gwang-seok
|
2020-07-15 14:41
라인
Biogen, Esai to test another Alzheimer’s drug in phase-3 study
Biogen and Eisai, whose collaboration for experimental Alzheimer’s drug adu...
by Kim Yun-mi
|
2020-07-15 12:42
라인
Imported infections hamper efforts to stabilize new virus cases
Korea's new virus cases stayed below 40 for the second day on Tuesday, ...
by Lee Han-soo
|
2020-07-15 12:41
라인
SNUH starts administering Inovio's Covid-19 vaccine to patients
Seoul National University Hospital (SNUH) said that it has administered the...
by Lee Han-soo
|
2020-07-15 12:41
라인
‘Korean New Deal’ to kick off telemedicine platform
The government announced on Tuesday that it would foster the non-face-to-fa...
by Choi Gwang-seok
|
2020-07-15 10:31
라인
Severance unveils 3-step treatment program to treat advanced liver cancer
Researchers at Severance Hospital said that they could increase the surviva...
by Lee Han-soo
|
2020-07-14 17:48
라인
Medytox, Daewoong keep brawling over US agency’s ruling
Medytox and Daewoong Pharmaceutical continued to brawl over the U.S. Intern...
by Lee Han-soo
|
2020-07-14 17:30
라인
National Bio Big Data project begins with 1st patient registration
Seoul National University Hospital’s Rare Disease Center said it has regist...
by Choi Gwang-seok
|
2020-07-14 15:29
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top